Notice of Results Investor Presentation

Collagen Solutions Plc

(the "Company" or the "Group")

Notice of Results

Investor presentation

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen-based biomaterials for use in research, diagnostics, medical devices, and regenerative medicine, announces they will issue their preliminary results for the year ending 31 March 2016 on Monday, 11 July 2016.

Analyst presentation

A briefing for analysts will take place at the offices of Walbrook PR, 4 Lombard Street, London EC3V 9HD at 9.30am on Monday, 11 July 2016.

Investor presentation

An afternoon presentation for investors will take place on Tuesday, 12 July in the Black Bar, upstairs at Rocket Bar, 6 Adams Court, Old Broad St, London, EC2N 1DX at 4.30pm for a 4.45pm start.

The presentations will be delivered by the new CEO, Jamal Rushdy, who will provide an updated vision and strategic focus for the Company which is reflected in the new website. An updated presentation is also available at http://ir.collagensolutions.com/content/investors/presentations.asp

If you would like to register to attend either of these events, or require further information, please contact Walbrook PR on 020 7933 8780 or email [email protected].

Enquiries: 

About Collagen Solutions: www.collagensolutions.com

Collagen Solutions Plc is a global provider of medical grade collagen formulations and components for use in regenerative medicine, medical devices, research, and in-vitro diagnostics. The capabilities of the Company include the provision of native, soluble and powdered collagen formulations, processed and semi-processed tissues such as pericardium, bone, and blood vessels, and expertise in the development and contract manufacture of collagen components for use as engineered tissue scaffolds and other medical devices. These products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology. Collagen Solutions' unique offering extends beyond material supply and contract services through the highly skilled staff who support customers through the various stages of development and regulatory approval.